Form 4: Jupiter Neurosciences Director Converts Convertible Notes to Common Stock
SEC Form 4 Filing
Director Allison W. Brady converted convertible notes into 21,750 shares of common stock in Jupiter Neurosciences.
Summary
- Allison W. Brady, a director at Jupiter Neurosciences, converted convertible notes into common stock.
- The transaction occurred on January 22, 2025.
- A total of 21,750 shares of common stock were issued as a result of the conversion.
- The convertible notes were originally issued on September 9, 2021, with a principal balance of $50,400 and a conversion price of $2.80 per share.
- The converted shares are subject to a 180-day lock-up period following the company's initial public offering, as per an agreement dated November 27, 2024.
Sentiment
Score: 6
Explanation: The document reflects a routine insider transaction, which is neither particularly positive nor negative. It is a standard part of the company's financial structure.
Industry Context
This transaction is a standard insider activity related to the conversion of debt into equity, which is common in companies that have recently gone public or are in the process of doing so. It reflects the conversion of a debt instrument into equity, which is a typical part of the capital structure of many companies.
Comparison to Industry Standards
- The conversion of convertible notes into common stock is a common practice, especially for companies that have recently completed an IPO or are in the process of doing so.
- Lock-up agreements are also standard practice to prevent large amounts of stock from being sold immediately after an IPO, which could negatively impact the share price.
- Similar transactions can be seen in companies like Amyris, Inc. and Cassava Sciences, Inc., where insiders have converted debt or options into equity.
Stakeholder Impact
- The conversion of notes to stock may slightly dilute existing shareholders' ownership, but this is a standard part of the company's capital structure.
Key Dates
| Date | Description |
|---|---|
| 09/09/2021 | Date of the original convertible promissory note. |
| 11/27/2024 | Date of the Lock-Up Agreement with Dominari Securities LLC. |
| 01/22/2025 | Date of the conversion of convertible notes to common stock. |
| 01/24/2025 | Date of the signature of the SEC Form 4. |
Keywords
convertible notes, common stock, insider transaction, Jupiter Neurosciences, share conversion, lock-up agreement, director, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.